ArticleCureus2025
Contrast-Enhanced Ultrasound of a Hepatic Perivascular Epithelioid Cell Tumor: A Case Report and Literature Review.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Malignant hepatic perivascular epithelioid cell tumor: A case report and literature review.Radiology case reports · 2026Article
- Characteristics and Treatment of Primary Hepatic Perivascular Epithelioid Cell Tumor (PEComa) in Adults: A Systematic Review.Cancers · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary hepatic perivascular epithelioid cell tumor (PEComa) is an exceptionally rare mesenchymal neoplasm of borderline malignancy, with limited documentation of its contrast-enhanced ultrasound (CEUS) features in medical literature. In this context, we present a 53-year-old male patient without chronic liver disease, who exhibited a well-circumscribed hypoechoic left hepatic lobe mass on conventional ultrasonography. Subsequent CEUS demonstrated characteristics indicative of malignant tumors, with specific manifestations during the arterial phase, thereby informing clinical decision-making toward surgical resection. Histopathological confirmation of capsular-invasive PEComa underscores the utility of CEUS in characterizing such lesions, particularly in middle-aged patients with incidental solitary hepatic masses lacking predisposing risk factors. These findings advocate for the integration of CEUS into diagnostic algorithms to enhance specificity in atypical hepatic tumor evaluations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.